Xue Wu Song
Director of Finance/CFO bei BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD.
Profil
Xue Wu Song is currently working as the VP, Chief Financial & Accounting Officer at Beijing Centergate Technologies (Holding) Co., Ltd.
since 2022.
Additionally, Mr. Song is also a Member-Supervisory Board at DUO Pharmaceutical Co., Ltd.
since 2016.
Mr. Song completed their undergraduate degree at Renmin University of China and their graduate degree at Beihang University.
Aktive Positionen von Xue Wu Song
Unternehmen | Position | Beginn |
---|---|---|
BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD. | Director of Finance/CFO | 26.08.2014 |
DUO Pharmaceutical Co., Ltd.
DUO Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology DUO Pharmaceutical Co., Ltd. is a holding company that engages in the production of pharmaceutical products. It offers medicines in the form of tablets, capsules, injections, and granules. Its products include tramadol hydrochloride tablets and injections, pediatric paracetamol enema, Vitamin C injections, cephalexin and trimethoprim capsules, glucose injections, and lincomycin hydrochloride injections. The company was founded on December 15, 1999 and is headquartered in Jiamusi, China. | Director/Board Member | 08.01.2016 |
Ausbildung von Xue Wu Song
Renmin University of China | Undergraduate Degree |
Beihang University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
DUO Pharmaceutical Co., Ltd.
DUO Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology DUO Pharmaceutical Co., Ltd. is a holding company that engages in the production of pharmaceutical products. It offers medicines in the form of tablets, capsules, injections, and granules. Its products include tramadol hydrochloride tablets and injections, pediatric paracetamol enema, Vitamin C injections, cephalexin and trimethoprim capsules, glucose injections, and lincomycin hydrochloride injections. The company was founded on December 15, 1999 and is headquartered in Jiamusi, China. | Health Technology |